198 related articles for article (PubMed ID: 2032228)
21. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
Abdel-Mageed A; Agrawal KC
Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
[TBL] [Abstract][Full Text] [Related]
22. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
Gudas JM; Klein RC; Oka M; Cowan KH
Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
[TBL] [Abstract][Full Text] [Related]
23. c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells.
Collins JF; Herman P; Schuch C; Bagby GC
J Clin Invest; 1992 May; 89(5):1523-7. PubMed ID: 1569190
[TBL] [Abstract][Full Text] [Related]
24. Functional estrogen receptor beta in colon cancer cells.
Fiorelli G; Picariello L; Martineti V; Tonelli F; Brandi ML
Biochem Biophys Res Commun; 1999 Aug; 261(2):521-7. PubMed ID: 10425218
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
Yang DC; Jiang XP; Elliott RL; Head JF
Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
[TBL] [Abstract][Full Text] [Related]
26. Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells.
Scala S; Pacelli R; Iaffaioli RV; Normanno N; Pepe S; Frasci G; Genua G; Tsuruo T; Tagliaferri P; Bianco AR
Cancer Res; 1991 Sep; 51(18):4898-902. PubMed ID: 1893380
[TBL] [Abstract][Full Text] [Related]
27. Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells.
Kaji M; Yonemura Y; Harada S; Liu X; Terada I; Yamamoto H
Cancer Gene Ther; 1996; 3(6):393-404. PubMed ID: 8988842
[TBL] [Abstract][Full Text] [Related]
28. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM; Lau KM; Mok SC; Syed V
Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
[TBL] [Abstract][Full Text] [Related]
29. Effect of nucleolar P120 expression level on the proliferation capacity of breast cancer cells.
Fonagy A; Swiderski C; Ostrovsky AM; Bolton WE; Freeman JW
Cancer Res; 1994 Apr; 54(7):1859-64. PubMed ID: 8137301
[TBL] [Abstract][Full Text] [Related]
30. Multigene targeting with antisense oligodeoxynucleotides: an exploratory study using primary human leukemia cells.
Opalinska JB; Machalinski B; Ratajczak J; Ratajczak MZ; Gewirtz AM
Clin Cancer Res; 2005 Jul; 11(13):4948-54. PubMed ID: 16000594
[TBL] [Abstract][Full Text] [Related]
31. Use of c-myb antisense oligonucleotides to increase the sensitivity of human colon cancer cells to cisplatin.
Funato T; Satou J; Kozawa K; Fujimaki S; Miura T; Kaku M
Oncol Rep; 2001; 8(4):807-10. PubMed ID: 11410788
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
33. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
Rosolen A; Whitesell L; Ikegaki N; Kennett RH; Neckers LM
Cancer Res; 1990 Oct; 50(19):6316-22. PubMed ID: 2205380
[TBL] [Abstract][Full Text] [Related]
34. Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.
Venturelli D; Mariano MT; Szczylik C; Valtieri M; Lange B; Crist W; Link M; Calabretta B
Cancer Res; 1990 Nov; 50(22):7371-5. PubMed ID: 2224864
[TBL] [Abstract][Full Text] [Related]
35. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
36. Expression and transcriptional regulation of the human alpha1, 3-fucosyltransferase 4 (FUT4) gene in myeloid and colon adenocarcinoma cell lines.
Taniguchi A; Suga R; Matsumoto K
Biochem Biophys Res Commun; 2000 Jun; 273(1):370-6. PubMed ID: 10873613
[TBL] [Abstract][Full Text] [Related]
37. Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.
Jiang XP; Elliott RL; Head JF
Anticancer Res; 2010 Mar; 30(3):759-65. PubMed ID: 20392994
[TBL] [Abstract][Full Text] [Related]
38. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
Del Bufalo D; Cucco C; Leonetti C; Citro G; D'Agnano I; Benassi M; Geiser T; Zon G; Calabretta B; Zupi G
Br J Cancer; 1996 Aug; 74(3):387-93. PubMed ID: 8695353
[TBL] [Abstract][Full Text] [Related]
39. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
40. Intrinsic drug resistance in a human medullary thyroid carcinoma cell line: association with overexpression of mdrl gene and low proliferation fraction.
Yang KP; Liang YF; Samaan NA
Anticancer Res; 1991; 11(3):1065-8. PubMed ID: 1888139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
